Related Experiment Video
Updated: May 31, 2026

09:20
Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
Published on: July 3, 2025
[Lymphadenitis caused by nontuberculous mycobacteriae].
Eeva Salo1, Marjo Renko, Petri Koivunen
1HUS:n lastenklinikka.
Summary
Nontuberculous mycobacteria lymphadenitis is rising in Finland after universal BCG vaccination stopped. This condition causes neck masses in children, often resolving but sometimes requiring observation due to surgical risks.
Area of Science:
- Infectious Diseases
- Pediatrics
- Microbiology
Context:
- Increased incidence of lymphadenitis caused by nontuberculous mycobacteria (NTM) in Finland since 2006, following the cessation of universal BCG vaccination.
- Clinical presentation involves a slowly developing unilateral cervicofacial mass in otherwise healthy children.
- Untreated lymphadenitis can lead to suppuration, draining sinus formation, and scarring.
Purpose:
- To describe the epidemiology and clinical course of nontuberculous mycobacteria lymphadenitis in children in Finland.
- To discuss management strategies, including surgical considerations and the role of observation.
- To highlight the need for parental information and support.
Summary:
- Lymphadenitis due to nontuberculous mycobacteria is increasingly diagnosed in Finnish children post-BCG vaccination cessation.
- The condition typically manifests as a neck mass, which may spontaneously resolve or lead to sinus formation and scarring.
- Surgical intervention is curative but often contraindicated due to potential facial nerve damage, favoring observation in select cases.
Impact:
- Informs clinicians about the rising trend and clinical presentation of NTM lymphadenitis in a post-vaccination era.
- Provides guidance on management options, emphasizing observation when surgery poses significant risks.
- Underscores the importance of patient and parental education and support for this condition.
Related Concept Videos
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...